Top Abstract
Presenter: Dr Lilian Downie, BabyScreen+
Scalable informed consent using an online platform, Genetics Adviser. Results from the first 500 families in BabyScreen+
Oxford Nanopore Technologies
Cora Vacher, PhD. Market Segment Manager, Human Genetics. Oxford Nanopore Technologies
Amazon
Dr. Rowland Illing, Director & Chief Medical Officer, International Public Sector Health at Amazon Web Services (AWS)
Illumina
Dr. Kevin P Hall, PhD ,VP, Distinguished Scientist, Illumina, and Prof. Sebastian Lunke, BSc, PhD, FFSc(RCPA). Head of Division of Genetics and Genomics at the Victorian Clinical Genetics Services
Up/Downstream Ecosystem
Panel: Up/Downstream Ecosystem
Moderator: Dr. Robert Green (ICoNS Co-Chair)
Panelists: Dr. Vanessa Almendro/Danaher Corp, Dr. Paul Kruszka/GeneDx, Dr. Jennifer Ibrahim/Sanofi, TBD



BabySeq
Dr. Robert C. Green MD, MPH, Professor of Medicine (Genetics), Harvard Medical School, Director Genomes2People, and Ingrid A. Holm, MD, MPH, Endowed Chair in Genetics and Genomics | Boston Children's Hospital

ScreenPlus
Drs. Melissa Wasserstein, Chief, Division of Pediatric Genetic Medicine Children's Hospital at Montefiore & Michael Gelb, Professor and Boris and Barbara L. Weinstein Endowed Chair in Chemistry, Adjunct Professor of Biochemistry, Univ of Washington
Newborn Sequencing Economics
Panel: Newborn Sequencing Economics
Moderator: Dr. Hadley Smith, Health economist researching pediatric genomic medicine | Assistant Professor, Harvard Medical School and Harvard Pilgrim Health Care Institute
Panelists: Dr. James Buchanan, Dr. Sarah Norris, Matthew Aujla

Closing Announcements
Nicolas Encina, Exec. Director ICoNS, Director of Strategy Precision Population Health, Harvard School of Public Health
Closing Announcements
